|Global spread and persistence of dengue|
JL Kyle, E Harris
Annu. Rev. Microbiol. 62, 71-92, 2008
|Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis|
H Nair, WA Brooks, M Katz, A Roca, JA Berkley, SA Madhi, ...
The Lancet 378 (9807), 1917-1930, 2011
MG Guzman, E Harris
The Lancet 385 (9966), 453-465, 2015
|Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection|
K Stettler, M Beltramello, DA Espinosa, V Graham, A Cassotta, S Bianchi, ...
Science 353 (6301), 823-826, 2016
|The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity|
M Beltramello, KL Williams, CP Simmons, A Macagno, L Simonelli, ...
Cell host & microbe 8 (3), 271-283, 2010
|Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis|
K Clyde, JL Kyle, E Harris
Journal of virology 80 (23), 11418-11431, 2006
|Antibody-dependent enhancement of severe dengue disease in humans|
LC Katzelnick, L Gresh, ME Halloran, JC Mercado, G Kuan, A Gordon, ...
Science 358 (6365), 929-932, 2017
|Emergence and global spread of a dengue serotype 3, subtype III virus|
WB Messer, DJ Gubler, E Harris, K Sivananthan, AM De Silva
Emerging infectious diseases 9 (7), 800, 2003
|The WHO dengue classification and case definitions: time for a reassessment|
JL Deen, E Harris, B Wills, A Balmaseda, SN Hammond, C Rocha, ...
The Lancet 368 (9530), 170-173, 2006
|Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification|
SJ Balsitis, KL Williams, R Lachica, D Flores, JL Kyle, E Mehlhop, ...
PLoS Pathog 6 (2), e1000790, 2010
|Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua|
SN Hammond, A Balmaseda, L Perez, Y Tellez, SI Saborío, JC Mercado, ...
The American journal of tropical medicine and hygiene 73 (6), 1063-1070, 2005
|Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons|
MS Diamond, TG Roberts, D Edgil, B Lu, J Ernst, E Harris
Journal of virology 74 (11), 4957-4966, 2000
|Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR|
E Harris, TG Roberts, L Smith, J Selle, LD Kramer, S Valle, E Sandoval, ...
Journal of clinical microbiology 36 (9), 2634-2639, 1998
|Murine model for dengue virus-induced lethal disease with increased vascular permeability|
S Shresta, KL Sharar, DM Prigozhin, PR Beatty, E Harris
Journal of virology 80 (20), 10208-10217, 2006
|Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission|
T Tabata, M Petitt, H Puerta-Guardo, D Michlmayr, C Wang, ...
Cell host & microbe 20 (2), 155-166, 2016
|Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T-and B-cell-dependent immunity are less critical|
S Shresta, JL Kyle, HM Snider, M Basavapatna, PR Beatty, E Harris
Journal of virology 78 (6), 2701-2710, 2004
|Serotype-specific differences in clinical manifestations of dengue|
A Balmaseda, SN Hammond, L Pérez, Y Tellez, SI Saborío, JC Mercado, ...
The American journal of tropical medicine and hygiene 74 (3), 449-456, 2006
|Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.|
E Harris, E Videa, L Pérez, E Sandoval, Y Téllez, ML Perez, R Cuadra, ...
The American journal of tropical medicine and hygiene 63 (1), 5-11, 2000
|Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination|
PR Beatty, H Puerta-Guardo, SS Killingbeck, DR Glasner, K Hopkins, ...
Science translational medicine 7 (304), 304ra141-304ra141, 2015
|Infection of human cells by dengue virus is modulated by different cell types and viral strains|
MS Diamond, D Edgil, TG Roberts, B Lu, E Harris
Journal of virology 74 (17), 7814-7823, 2000